menu
    • menu

    Company profile for Ichnos Sciences

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    In the way we’re structured, in the people we hire, in our trials and technology—and in the way we research and innovate transformative solutions on the frontiers of oncology and autoimmune disease. Shifting toward disease-centric therapies, we seek to treat patients holistically, allowing us to target diseases and their consequences on the human body on multiple levels.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ichnos SciencesSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Route de la Corniche 5A, 1066 Epalinges
    Telephone
    Telephone
    +1-201-786-3216
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ichnossciences.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ichnos-sciences/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    IGI's Trispecific Antibody For Multiple Myeloma Published In Nature Cancer
    IGI's Trispecific Antibody For Multiple Myeloma Published In Nature Cancer

    11 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/11/2944300/0/en/IGI-Announces-Publication-in-Nature-Cancer-on-ISB-2001-IGI-s-Innovative-Trispecific-Antibody-for-Relapsed-Refractory-Multiple-Myeloma.html

    GLOBENEWSWIRE
    11 Sep 2024
    Share Share
    Ichnos and Glenmark take a collaborative leap
    Ichnos and Glenmark take a collaborative leap

    30 Jan 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ichnos-and-glenmark-take-a-collaborative-leap-to-accelerate-innovation-in-cancer-treatment-with-their-alliance---ichnos-glenmark-innovation-302048131.html

    PR NEWSWIRE
    30 Jan 2024
    Share Share
    Ichnos Sciences Data Selected For Presentation At The 65Th Ash Annual Meeting
    Ichnos Sciences Data Selected For Presentation At The 65Th Ash Annual Meeting

    09 Nov 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ichnos-sciences-data-selected-for-presentation-at-the-65th-ash-annual-meeting-301982597.html

    PR NEWSWIRE
    09 Nov 2023
    Share Share
    Ichnos Sciences inks agreement with Astria Therapeutics for OX40
    Ichnos Sciences inks agreement with Astria Therapeutics for OX40

    13 Oct 2023

    // INDIAN PHARMA POST

    https://www.indianpharmapost.com/news/ichnos-sciences-inks-agreement-with-astria-therapeutics-for-ox40-antagonist-monoclonal-antibody-portfolio-14782

    INDIAN PHARMA POST
    13 Oct 2023
    Share Share
    Astria pays Ichnos $15M to join eczema race led by Amgen, Sanofi
    Astria pays Ichnos $15M to join eczema race led by Amgen, Sanofi

    12 Oct 2023

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/astria-scratches-dealmaking-itch-paying-ichnos-15m-join-eczema-race-led-amgen-sanofi

    Nick Paul Taylor FIERCE BIOTECH
    12 Oct 2023
    Share Share
    Astria Announces Exclusive Worldwide License Agreement with Ichnos Sciences
    Astria Announces Exclusive Worldwide License Agreement with Ichnos Sciences

    11 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231011280502/en

    BUSINESSWIRE
    11 Oct 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search